doi: 10.1016/j.bmc.2012.04.032.
Epub 2012 Apr 21.
Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors
Affiliations
- PMID: 22579621
- DOI: 10.1016/j.bmc.2012.04.032
Item in Clipboard
Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors
Bioorg Med Chem.
.
Abstract
Histone deacetylase (HDAC) inhibitors have emerged as a new class of anticancer agents, targeting the biological processes including cell cycle, apoptosis and differentiation. In the present study, a series of 1,3,4-thiadiazole based hydroxamic acids were developed as potent HDAC inhibitors. Some of them showed good inhibitory activity in HDAC enzyme assay and potent growth inhibition in some tumor cell lines. Among them, compound 6i (IC(50) = 0.089 μM), exhibited better inhibitory effect compared with SAHA (IC(50) = 0.15 μM).
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
New aryldithiolethione derivatives as potent histone deacetylase inhibitors.Bioorg Med Chem. 2010 Jun 15;18(12):4187-94. doi: 10.1016/j.bmc.2010.05.011. Epub 2010 May 7. Bioorg Med Chem. 2010. PMID: 20576572
-
Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity.Bioorg Med Chem Lett. 2010 Jul 1;20(13):3906-10. doi: 10.1016/j.bmcl.2010.05.020. Epub 2010 May 15. Bioorg Med Chem Lett. 2010. PMID: 20605448
-
Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDAC inhibitors.Arch Pharm Res. 2012 Oct;35(10):1723-32. doi: 10.1007/s12272-012-1003-0. Epub 2012 Nov 9. Arch Pharm Res. 2012. PMID: 23139122
-
In vivo Anticancer Potential of Hydroxamic Acid Derivatives.Curr Top Med Chem. 2021;21(19):1737-1755. doi: 10.2174/1568026621666210813105240. Curr Top Med Chem. 2021. PMID: 34392823 Review.
-
Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges.Cancer Lett. 2009 Aug 8;280(2):233-41. doi: 10.1016/j.canlet.2009.02.019. Epub 2009 Apr 2. Cancer Lett. 2009. PMID: 19344997 Review.
Cited by
-
The structural requirements of histone deacetylase inhibitors: suberoylanilide hydroxamic acid analogs modified at the C6 position.Bioorg Med Chem Lett. 2012 Dec 1;22(23):7084-6. doi: 10.1016/j.bmcl.2012.09.093. Epub 2012 Oct 2. Bioorg Med Chem Lett. 2012. PMID: 23089527 Free PMC article.
-
Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety.Molecules. 2017 Dec 27;23(1):59. doi: 10.3390/molecules23010059. Molecules. 2017. PMID: 29280989 Free PMC article.
-
Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase.Molecules. 2024 Jan 1;29(1):238. doi: 10.3390/molecules29010238. Molecules. 2024. PMID: 38202821 Free PMC article. Review.
-
Virtual screening and experimental validation of novel histone deacetylase inhibitors.BMC Pharmacol Toxicol. 2016 Jul 21;17(1):32. doi: 10.1186/s40360-016-0075-8. BMC Pharmacol Toxicol. 2016. PMID: 27443303 Free PMC article.
-
Design and Synthesis of Small Molecules as Potent Staphylococcus aureus Sortase A Inhibitors.Antibiotics (Basel). 2020 Oct 16;9(10):706. doi: 10.3390/antibiotics9100706. Antibiotics (Basel). 2020. PMID: 33081148 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
